$2.42T
Total marketcap
$62.95B
Total volume
BTC 50.84%     ETH 17.01%
Dominance

BioPharma Credit PLC B3P.MU Stock

0.75 EUR {{ price }} -0.662251% {{change_pct}}%
COUNTRY
Germany
Exchange
Munich
Market Cap
1.07B EUR
LOW - HIGH [24H]
0.76 - 0.76 EUR
VOLUME [24H]
500 EUR
{{ volume }}
P/E Ratio
12.71
Earnings per share
0.06 EUR

BioPharma Credit PLC Price Chart

BioPharma Credit PLC B3P.MU Financial and Trading Overview

BioPharma Credit PLC stock price 0.75 EUR
Previous Close 0.82 EUR
Open 0.81 EUR
Bid 0.81 EUR x 0
Ask 0.89 EUR x 0
Day's Range 0.81 - 0.81 EUR
52 Week Range 0.81 - 0.81 EUR
Volume 500 EUR
Avg. Volume N/A
Market Cap 1.15B EUR
Beta (5Y Monthly) 0.231034
PE Ratio (TTM) 13.644068
EPS (TTM) 0.06 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

B3P.MU Valuation Measures

Enterprise Value 1.13B EUR
Trailing P/E 13.644068
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 5.287521
Price/Book (mrq) 0.7938856
Enterprise Value/Revenue 5.19
Enterprise Value/EBITDA N/A

Trading Information

BioPharma Credit PLC Stock Price History

Beta (5Y Monthly) 0.231034
52-Week Change N/A
S&P500 52-Week Change 20.43%
52 Week High 0.81 EUR
52 Week Low 0.81 EUR
50-Day Moving Average N/A
200-Day Moving Average N/A

B3P.MU Share Statistics

Avg. Volume (3 month) N/A
Avg. Daily Volume (10-Days) N/A
Shares Outstanding 914.25M
Float 1.13B
Short Ratio N/A
% Held by Insiders 7.69%
% Held by Institutions 39.21%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.07
Trailing Annual Dividend Yield 8.53%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 83.56%
Operating Margin (ttm) 83.57%
Gross Margin 100.00%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) 8.33%
Return on Equity (ttm) 13.49%

Income Statement

Revenue (ttm) 218.17M EUR
Revenue Per Share (ttm) 0.16 EUR
Quarterly Revenue Growth (yoy) 174.10%
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) 182.31M EUR
Diluted EPS (ttm) 0.059
Quarterly Earnings Growth (yoy) 180.40%

Balance Sheet

Total Cash (mrq) 120.53M EUR
Total Cash Per Share (mrq) 0.09 EUR
Total Debt (mrq) 0 EUR
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 5.337
Book Value Per Share (mrq) 1.014

Cash Flow Statement

Operating Cash Flow (ttm) 184.28M EUR
Levered Free Cash Flow (ttm) 124.09M EUR

Profile of BioPharma Credit PLC

Country Germany
State N/A
City London
Address 65 Gresham Street
ZIP EC2V 7NQ
Phone N/A
Website https://www.bpcruk.com
Industry
Sector(s)
Full Time Employees N/A

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

Q&A For BioPharma Credit PLC Stock

What is a current B3P.MU stock price?

BioPharma Credit PLC B3P.MU stock price today per share is 0.75 EUR.

How to purchase BioPharma Credit PLC stock?

You can buy B3P.MU shares on the Munich exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for BioPharma Credit PLC?

The stock symbol or ticker of BioPharma Credit PLC is B3P.MU.

How many shares does BioPharma Credit PLC have in circulation?

The max supply of BioPharma Credit PLC shares is 1.43B.

What is BioPharma Credit PLC Price to Earnings Ratio (PE Ratio)?

BioPharma Credit PLC PE Ratio is 12.71186400 now.

What was BioPharma Credit PLC earnings per share over the trailing 12 months (TTM)?

BioPharma Credit PLC EPS is 0.06 EUR over the trailing 12 months.